Ann Dermatol.  2015 Dec;27(6):763-764. 10.5021/ad.2015.27.6.763.

Melasma in a Male Patient due to Estrogen Therapy for Prostate Cancer

• Ogita A
• Funasaka Y
• Ansai SI
• Kawana S
• Saeki H

• KMID: 2157457
• DOI: http://doi.org/10.5021/ad.2015.27.6.763

Abstract

No abstract available.

MeSH Terms

Estrogens*
Humans
Male*
Melanosis*
Prostate*
Prostatic Neoplasms*
Estrogens

Figure

• 

  Fig. 1 (A) Symmetric, light to dark brown macules on the malar, nose, and upper part of the eyebrows with sharply demarcated margins. (B) The macules on his face mostly disappeared by 6 months after the administration of 1.5 g tranexamic acid.

Reference

1. Sialy R, Hassan I, Kaur I, Dash RJ. Melasma in men: a hormonal profile. J Dermatol. 2000; 27:64–65.

2. Sarkar R, Puri P, Jain RK, Singh A, Desai A. Melasma in men: a clinical, aetiological and histological study. J Eur Acad Dermatol Venereol. 2010; 24:768–772.

3. Tadokoro T, Rouzaud F, Itami S, Hearing VJ, Yoshikawa K. The inhibitory effect of androgen and sex-hormone-binding globulin on the intracellular cAMP level and tyrosinase activity of normal human melanocytes. Pigment Cell Res. 2003; 16:190–197.

4. O'Brien TJ, Dyall-Smith D, Hall AP. Melasma of the forearms. Australas J Dermatol. 1997; 38:35–37.

5. Burkhart CG. Chloasma in a man due to oral hormone replacement. Skinmed. 2006; 5:46–47.

6. Famenini S, Gharavi NM, Beynet DP. Finasteride associated melasma in a Caucasian male. J Drugs Dermatol. 2014; 13:484–486.